BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11578487)

  • 21. Validation of the histologic grading for ovarian clear cell adenocarcinoma: a retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study Group.
    Yamamoto S; Kasajima A; Takano M; Yaegashi N; Fujiwara H; Kuzuya K; Kigawa J; Tsuda H; Kurachi H; Kikuchi Y; Sugiyama T; Tsuda H; Moriya T
    Int J Gynecol Pathol; 2011 Mar; 30(2):129-38. PubMed ID: 21293288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion-weighted MRI of epithelial ovarian cancers: correlation of apparent diffusion coefficient values with histologic grade and surgical stage.
    Oh JW; Rha SE; Oh SN; Park MY; Byun JY; Lee A
    Eur J Radiol; 2015 Apr; 84(4):590-5. PubMed ID: 25623826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer.
    Nagele F; Petru E; Medl M; Kainz C; Graf AH; Sevelda P
    Obstet Gynecol; 1995 Aug; 86(2):259-64. PubMed ID: 7617357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic value of nuclear grading and the revised FIGO grading of endometrial adenocarcinoma.
    Ayhan A; Taskiran C; Yuce K; Kucukali T
    Int J Gynecol Pathol; 2003 Jan; 22(1):71-4. PubMed ID: 12496701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Assessment of different histoprognosis grading systems for primary ovarian cancer: 100 patients given the same treatment for primary ovarian adenocarcinoma].
    Penault-Llorca F; Levrel O; Clémenson A; Kwiatkowski F; Pomel C; Fouilhoux G; De Latour M; Curé H; Déchelotte P; Fonck Y; Dauplat J
    J Gynecol Obstet Biol Reprod (Paris); 2000 Oct; 29(6):548-54. PubMed ID: 11084461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.
    Gilks CB; Ionescu DN; Kalloger SE; Köbel M; Irving J; Clarke B; Santos J; Le N; Moravan V; Swenerton K;
    Hum Pathol; 2008 Aug; 39(8):1239-51. PubMed ID: 18602670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the reproducibility of the revised 1988 International Federation of Gynecology and Obstetrics grading system of endometrial cancers with special emphasis on nuclear grading.
    Nielsen AL; Thomsen HK; Nyholm HC
    Cancer; 1991 Nov; 68(10):2303-9. PubMed ID: 1913466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Grading of ovarian carcinomas.
    Mayr D; Diebold J
    Int J Gynecol Pathol; 2000 Oct; 19(4):348-53. PubMed ID: 11109164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome in endometrial carcinoma favors a two- instead of a three-tiered grading system.
    Scholten AN; Creutzberg CL; Noordijk EM; Smit VT
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1067-74. PubMed ID: 11958903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas.
    Hasegawa T; Yamamoto S; Nojima T; Hirose T; Nikaido T; Yamashiro K; Matsuno Y
    Hum Pathol; 2002 Jan; 33(1):111-5. PubMed ID: 11823981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The reproducibility of a binary tumor grading system for uterine endometrial endometrioid carcinoma, compared with FIGO system and nuclear grading.
    Sagae S; Saito T; Satoh M; Ikeda T; Kimura S; Mori M; Sato N; Kudo R
    Oncology; 2004; 67(5-6):344-50. PubMed ID: 15713989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma.
    Malpica A; Deavers MT; Tornos C; Kurman RJ; Soslow R; Seidman JD; Munsell MF; Gaertner E; Frishberg D; Silva EG
    Am J Surg Pathol; 2007 Aug; 31(8):1168-74. PubMed ID: 17667538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interobserver agreement in the cytologic grading of atypia in neoplastic pancreatic mucinous cysts with the 2-tiered approach.
    Goyal A; Abdul-Karim FW; Yang B; Patel JB; Brainard JA
    Cancer Cytopathol; 2016 Dec; 124(12):909-916. PubMed ID: 27525382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Confirmation of the prognostic value of the ECPI-1 score (myometrial invasion, DNA-ploidy and mean shortest nuclear axis) in FIGO stage I endometrial cancer patients with long follow-up.
    Baak JP; Snijders WP; Van Diest PJ; Armee-Horváth E; Kenemans P
    Int J Gynecol Cancer; 1995 Mar; 5(2):112-116. PubMed ID: 11578464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up.
    Shimizu Y; Kamoi S; Amada S; Akiyama F; Silverberg SG
    Cancer; 1998 Mar; 82(5):893-901. PubMed ID: 9486579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic factors for survival of ovarian epithelial cancers: apropos of 287 cases].
    Brun JL; Bouzigon E; Saurel J; Chêne G; Briex M; Brun G; Hocke C
    Gynecol Obstet Fertil; 2000 Mar; 28(3):223-31. PubMed ID: 10786403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.
    Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z
    Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of histologic grading of ovarian carcinomas.
    Sato Y; Shimamoto T; Amada S; Asada Y; Hayashi T
    Int J Gynecol Pathol; 2003 Jan; 22(1):52-6. PubMed ID: 12496698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
    Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
    Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic variability of ovarian tumor grading by different pathologists.
    Baak JP; Langley FA; Talerman A; Delemarre JF
    Gynecol Oncol; 1987 Jun; 27(2):166-72. PubMed ID: 3570055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.